CA

Liviu Constantin Ciobanu



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liviu Constantin Ciobanu: Innovator in Antiandrogen Research

Introduction

Liviu Constantin Ciobanu is a notable inventor based in California, recognized for his contributions to the field of pharmaceuticals. He has developed innovative compounds that target androgen-dependent diseases, showcasing his expertise in medicinal chemistry.

Latest Patents

Ciobanu holds a patent for "Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety." This patent describes compounds that are effective in treating or reducing the likelihood of acquiring various androgen-dependent diseases, including prostate cancer, benign prostatic hyperplasia, and polycystic ovarian syndrome. The compounds can be formulated with pharmaceutically acceptable diluents or carriers and can be made into various pharmaceutical dosage forms. Additionally, combinations with other active pharmaceutical agents are disclosed in his patent.

Career Highlights

Ciobanu is associated with Endorecherche, Inc., where he continues to advance his research in the pharmaceutical industry. His work has significant implications for the treatment of conditions such as male hypogonadism, erectile dysfunction, and osteoporosis.

Collaborations

Throughout his career, Ciobanu has collaborated with esteemed colleagues, including Fernand Labrie and Shankar Mohan Singh. These collaborations have further enriched his research and development efforts in the field.

Conclusion

Liviu Constantin Ciobanu's innovative work in antiandrogen research has the potential to impact the treatment of various health conditions significantly. His contributions to the pharmaceutical industry exemplify the importance of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…